 Wei Perng
Concepts (396)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 32 | 2024 | 504 | 8.020 |
Why?
| | Prenatal Exposure Delayed Effects | 24 | 2025 | 563 | 6.720 |
Why?
| | Body Mass Index | 50 | 2025 | 2260 | 4.590 |
Why?
| | Pediatric Obesity | 15 | 2024 | 570 | 3.830 |
Why?
| | Diabetes, Gestational | 11 | 2025 | 308 | 3.280 |
Why?
| | Environmental Pollutants | 10 | 2025 | 142 | 3.110 |
Why?
| | Cardiovascular Diseases | 14 | 2025 | 1994 | 3.040 |
Why?
| | Pregnancy | 67 | 2025 | 6355 | 2.960 |
Why?
| | Birth Weight | 18 | 2024 | 499 | 2.900 |
Why?
| | Metabolomics | 14 | 2024 | 599 | 2.880 |
Why?
| | Biomarkers | 31 | 2024 | 3874 | 2.690 |
Why?
| | Non-alcoholic Fatty Liver Disease | 8 | 2023 | 258 | 2.540 |
Why?
| | Diet | 18 | 2024 | 1198 | 2.480 |
Why?
| | Weight Gain | 11 | 2023 | 503 | 2.380 |
Why?
| | DNA Methylation | 12 | 2024 | 604 | 2.190 |
Why?
| | Obesity | 26 | 2025 | 2859 | 2.150 |
Why?
| | Child | 83 | 2025 | 20636 | 2.130 |
Why?
| | Leptin | 10 | 2024 | 218 | 2.010 |
Why?
| | Body Composition | 15 | 2023 | 644 | 1.980 |
Why?
| | Epigenesis, Genetic | 10 | 2024 | 614 | 1.970 |
Why?
| | Endocrine Disruptors | 4 | 2024 | 40 | 1.950 |
Why?
| | Mothers | 9 | 2024 | 729 | 1.800 |
Why?
| | Female | 118 | 2025 | 68016 | 1.770 |
Why?
| | Environmental Exposure | 7 | 2024 | 458 | 1.750 |
Why?
| | Metabolic Syndrome | 5 | 2021 | 338 | 1.680 |
Why?
| | Child Health | 4 | 2024 | 146 | 1.600 |
Why?
| | Insulin | 9 | 2024 | 2316 | 1.590 |
Why?
| | Prospective Studies | 35 | 2025 | 7035 | 1.560 |
Why?
| | Child, Preschool | 47 | 2025 | 10378 | 1.520 |
Why?
| | Overnutrition | 3 | 2021 | 30 | 1.510 |
Why?
| | Hypertension, Pregnancy-Induced | 6 | 2025 | 68 | 1.510 |
Why?
| | Adolescent | 53 | 2025 | 20158 | 1.490 |
Why?
| | Infant, Newborn | 33 | 2024 | 5688 | 1.470 |
Why?
| | Humans | 140 | 2025 | 128019 | 1.470 |
Why?
| | Overweight | 8 | 2024 | 522 | 1.460 |
Why?
| | Body Weight | 7 | 2022 | 930 | 1.440 |
Why?
| | Metabolome | 6 | 2024 | 319 | 1.430 |
Why?
| | Premature Birth | 6 | 2022 | 310 | 1.360 |
Why?
| | Stress, Psychological | 3 | 2023 | 1060 | 1.360 |
Why?
| | Risk Factors | 28 | 2025 | 9696 | 1.270 |
Why?
| | Body Height | 5 | 2018 | 192 | 1.270 |
Why?
| | Cohort Studies | 25 | 2025 | 5378 | 1.260 |
Why?
| | Long Interspersed Nucleotide Elements | 3 | 2013 | 30 | 1.240 |
Why?
| | Health Status | 3 | 2024 | 747 | 1.230 |
Why?
| | Fetal Blood | 6 | 2024 | 316 | 1.220 |
Why?
| | Pregnancy Outcome | 5 | 2022 | 389 | 1.180 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2428 | 1.170 |
Why?
| | Polycystic Ovary Syndrome | 3 | 2025 | 163 | 1.160 |
Why?
| | Waist Circumference | 9 | 2022 | 138 | 1.120 |
Why?
| | Fluorocarbons | 3 | 2025 | 109 | 1.090 |
Why?
| | Male | 70 | 2025 | 62757 | 1.080 |
Why?
| | Blood Pressure | 9 | 2025 | 1711 | 1.040 |
Why?
| | Anti-Mullerian Hormone | 2 | 2025 | 53 | 1.030 |
Why?
| | Metabolic Diseases | 4 | 2021 | 104 | 1.030 |
Why?
| | Insulin Resistance | 10 | 2024 | 1164 | 1.000 |
Why?
| | Blood Glucose | 10 | 2024 | 2092 | 1.000 |
Why?
| | Nutritional Status | 4 | 2020 | 326 | 0.990 |
Why?
| | Puberty | 4 | 2022 | 142 | 0.980 |
Why?
| | Amino Acids, Branched-Chain | 4 | 2022 | 36 | 0.980 |
Why?
| | Adiponectin | 6 | 2025 | 234 | 0.980 |
Why?
| | Mexico | 11 | 2023 | 190 | 0.980 |
Why?
| | Maternal Exposure | 5 | 2025 | 175 | 0.970 |
Why?
| | Phthalic Acids | 3 | 2024 | 45 | 0.940 |
Why?
| | Child Development | 7 | 2024 | 452 | 0.900 |
Why?
| | Young Adult | 26 | 2025 | 12281 | 0.900 |
Why?
| | Adult | 41 | 2025 | 35176 | 0.890 |
Why?
| | Skinfold Thickness | 4 | 2018 | 46 | 0.890 |
Why?
| | Maternal Nutritional Physiological Phenomena | 4 | 2023 | 169 | 0.880 |
Why?
| | C-Reactive Protein | 7 | 2017 | 396 | 0.870 |
Why?
| | Psychological Tests | 1 | 2023 | 130 | 0.810 |
Why?
| | Lead | 2 | 2021 | 56 | 0.810 |
Why?
| | Sexual Maturation | 2 | 2019 | 52 | 0.780 |
Why?
| | Self Report | 4 | 2023 | 796 | 0.780 |
Why?
| | Pregnancy Proteins | 1 | 2022 | 37 | 0.760 |
Why?
| | Azocines | 1 | 2021 | 8 | 0.760 |
Why?
| | Hyaenidae | 1 | 2021 | 4 | 0.750 |
Why?
| | Insulins | 1 | 2022 | 37 | 0.740 |
Why?
| | Infant | 27 | 2024 | 8912 | 0.730 |
Why?
| | Cardiovascular System | 1 | 2023 | 136 | 0.730 |
Why?
| | Ecology | 1 | 2022 | 108 | 0.730 |
Why?
| | Biological Evolution | 2 | 2022 | 425 | 0.720 |
Why?
| | Lipid Metabolism | 1 | 2024 | 491 | 0.720 |
Why?
| | Maternal Behavior | 1 | 2021 | 74 | 0.710 |
Why?
| | Hyperinsulinism | 1 | 2021 | 119 | 0.680 |
Why?
| | Triglycerides | 7 | 2023 | 523 | 0.680 |
Why?
| | Longitudinal Studies | 15 | 2025 | 2706 | 0.670 |
Why?
| | Prediabetic State | 1 | 2023 | 245 | 0.660 |
Why?
| | Racism | 1 | 2022 | 129 | 0.660 |
Why?
| | Lipids | 3 | 2020 | 619 | 0.660 |
Why?
| | Social Environment | 1 | 2021 | 291 | 0.650 |
Why?
| | Placenta | 3 | 2023 | 716 | 0.640 |
Why?
| | Islets of Langerhans | 2 | 2023 | 790 | 0.620 |
Why?
| | Massachusetts | 5 | 2025 | 158 | 0.620 |
Why?
| | Epidemiology | 1 | 2018 | 15 | 0.620 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2018 | 60 | 0.590 |
Why?
| | Menopause | 4 | 2025 | 291 | 0.590 |
Why?
| | Adipose Tissue | 5 | 2020 | 589 | 0.580 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2018 | 12 | 0.580 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2018 | 47 | 0.580 |
Why?
| | Linear Models | 8 | 2024 | 816 | 0.580 |
Why?
| | Cholesterol | 4 | 2023 | 406 | 0.570 |
Why?
| | Homeostasis | 2 | 2021 | 605 | 0.570 |
Why?
| | Body Fluid Compartments | 1 | 2017 | 6 | 0.560 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2017 | 25 | 0.560 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 39 | 0.560 |
Why?
| | Sex Characteristics | 2 | 2020 | 719 | 0.560 |
Why?
| | Breast Feeding | 5 | 2024 | 422 | 0.540 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2018 | 137 | 0.530 |
Why?
| | Socioeconomic Factors | 7 | 2024 | 1211 | 0.530 |
Why?
| | Bone and Bones | 1 | 2019 | 298 | 0.530 |
Why?
| | Androgens | 1 | 2018 | 173 | 0.530 |
Why?
| | Feeding Behavior | 3 | 2023 | 618 | 0.520 |
Why?
| | MicroRNAs | 1 | 2022 | 674 | 0.510 |
Why?
| | Anthropometry | 6 | 2022 | 204 | 0.510 |
Why?
| | Fetal Development | 1 | 2018 | 283 | 0.490 |
Why?
| | Micronutrients | 2 | 2013 | 88 | 0.480 |
Why?
| | Diabetes Mellitus | 2 | 2023 | 994 | 0.480 |
Why?
| | Gestational Age | 4 | 2024 | 868 | 0.480 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 307 | 0.470 |
Why?
| | alpha-Linolenic Acid | 1 | 2014 | 8 | 0.470 |
Why?
| | Maternal Welfare | 1 | 2014 | 19 | 0.470 |
Why?
| | Colombia | 6 | 2018 | 36 | 0.460 |
Why?
| | Hypertension | 3 | 2025 | 1234 | 0.450 |
Why?
| | Inflammation | 4 | 2022 | 2646 | 0.450 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 26 | 0.440 |
Why?
| | Alu Elements | 1 | 2013 | 27 | 0.440 |
Why?
| | Abdominal Fat | 3 | 2023 | 40 | 0.430 |
Why?
| | Homocysteine | 1 | 2013 | 149 | 0.420 |
Why?
| | Iron, Dietary | 1 | 2013 | 21 | 0.410 |
Why?
| | Intra-Abdominal Fat | 3 | 2023 | 88 | 0.410 |
Why?
| | Age Factors | 6 | 2025 | 3100 | 0.410 |
Why?
| | Fatty Acids | 2 | 2020 | 415 | 0.410 |
Why?
| | Growth Disorders | 1 | 2013 | 80 | 0.400 |
Why?
| | Follow-Up Studies | 8 | 2022 | 4853 | 0.390 |
Why?
| | Endotoxins | 2 | 2023 | 215 | 0.390 |
Why?
| | Poliomyelitis | 1 | 2012 | 36 | 0.380 |
Why?
| | American Heart Association | 2 | 2024 | 296 | 0.380 |
Why?
| | Infertility | 2 | 2022 | 50 | 0.380 |
Why?
| | Health Behavior | 4 | 2024 | 740 | 0.380 |
Why?
| | Postpartum Period | 3 | 2020 | 331 | 0.370 |
Why?
| | Sex Factors | 4 | 2019 | 1942 | 0.370 |
Why?
| | Diseases in Twins | 1 | 2012 | 176 | 0.360 |
Why?
| | Food Hypersensitivity | 2 | 2024 | 173 | 0.350 |
Why?
| | Boston | 4 | 2025 | 86 | 0.350 |
Why?
| | Twins | 1 | 2012 | 249 | 0.340 |
Why?
| | Causality | 2 | 2021 | 115 | 0.330 |
Why?
| | Atherosclerosis | 1 | 2013 | 403 | 0.320 |
Why?
| | Age of Onset | 2 | 2022 | 490 | 0.320 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2023 | 3625 | 0.320 |
Why?
| | C-Peptide | 2 | 2021 | 163 | 0.320 |
Why?
| | Fatty Liver | 2 | 2021 | 231 | 0.290 |
Why?
| | Principal Component Analysis | 3 | 2019 | 182 | 0.290 |
Why?
| | Logistic Models | 3 | 2023 | 1975 | 0.290 |
Why?
| | Cross-Sectional Studies | 7 | 2024 | 5034 | 0.280 |
Why?
| | United States | 8 | 2025 | 13785 | 0.270 |
Why?
| | Interleukin-6 | 3 | 2014 | 712 | 0.260 |
Why?
| | Multivariate Analysis | 5 | 2016 | 1492 | 0.250 |
Why?
| | Alkanesulfonic Acids | 2 | 2025 | 34 | 0.250 |
Why?
| | Regression Analysis | 3 | 2018 | 978 | 0.250 |
Why?
| | Liver | 3 | 2023 | 1826 | 0.250 |
Why?
| | Air Pollution | 2 | 2020 | 214 | 0.240 |
Why?
| | Colorado | 5 | 2024 | 4369 | 0.240 |
Why?
| | Incidence | 3 | 2023 | 2614 | 0.240 |
Why?
| | Odds Ratio | 3 | 2023 | 1018 | 0.240 |
Why?
| | Residence Characteristics | 2 | 2025 | 324 | 0.240 |
Why?
| | Hyperglycemia | 2 | 2018 | 326 | 0.240 |
Why?
| | Genome-Wide Association Study | 2 | 2023 | 1330 | 0.240 |
Why?
| | Child Behavior | 2 | 2024 | 235 | 0.230 |
Why?
| | Hyperandrogenism | 1 | 2025 | 18 | 0.230 |
Why?
| | Parabens | 1 | 2024 | 12 | 0.230 |
Why?
| | Genetic Association Studies | 2 | 2019 | 361 | 0.230 |
Why?
| | Prevalence | 3 | 2025 | 2541 | 0.230 |
Why?
| | Air Pollutants | 2 | 2020 | 310 | 0.220 |
Why?
| | Carbon Isotopes | 1 | 2024 | 123 | 0.220 |
Why?
| | Pregnancy Complications | 3 | 2020 | 487 | 0.220 |
Why?
| | Vulnerable Populations | 1 | 2025 | 157 | 0.220 |
Why?
| | Phenols | 1 | 2024 | 97 | 0.220 |
Why?
| | Birth Order | 1 | 2023 | 13 | 0.210 |
Why?
| | Asthma | 4 | 2023 | 2212 | 0.210 |
Why?
| | Exercise | 3 | 2024 | 1917 | 0.210 |
Why?
| | Cannabidiol | 1 | 2024 | 89 | 0.210 |
Why?
| | Parturition | 2 | 2022 | 69 | 0.200 |
Why?
| | Immunoglobulin E | 1 | 2024 | 329 | 0.200 |
Why?
| | Dronabinol | 1 | 2024 | 167 | 0.200 |
Why?
| | Phenotype | 2 | 2022 | 3039 | 0.200 |
Why?
| | Vegetables | 2 | 2020 | 147 | 0.200 |
Why?
| | Pregnant Women | 1 | 2023 | 114 | 0.190 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 42 | 0.190 |
Why?
| | Michigan | 2 | 2020 | 103 | 0.190 |
Why?
| | Adolescent Behavior | 2 | 2024 | 505 | 0.190 |
Why?
| | Middle Aged | 11 | 2025 | 30812 | 0.190 |
Why?
| | Toxoplasmosis, Animal | 1 | 2021 | 6 | 0.190 |
Why?
| | Carbohydrates | 1 | 2021 | 63 | 0.190 |
Why?
| | Plethysmography | 2 | 2022 | 106 | 0.190 |
Why?
| | Hand Strength | 1 | 2022 | 111 | 0.190 |
Why?
| | Health Status Disparities | 1 | 2024 | 254 | 0.190 |
Why?
| | Lysine | 1 | 2024 | 282 | 0.190 |
Why?
| | Antibodies, Protozoan | 1 | 2021 | 32 | 0.180 |
Why?
| | Cholesterol, LDL | 2 | 2022 | 357 | 0.180 |
Why?
| | Testosterone | 1 | 2025 | 369 | 0.180 |
Why?
| | Educational Status | 1 | 2023 | 470 | 0.180 |
Why?
| | Toxoplasma | 1 | 2021 | 38 | 0.180 |
Why?
| | Sarcopenia | 1 | 2022 | 74 | 0.180 |
Why?
| | Latin America | 1 | 2021 | 86 | 0.180 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2023 | 520 | 0.180 |
Why?
| | Cats | 1 | 2021 | 209 | 0.180 |
Why?
| | Protective Factors | 1 | 2021 | 91 | 0.180 |
Why?
| | Dermatitis, Atopic | 1 | 2024 | 319 | 0.180 |
Why?
| | Selection, Genetic | 1 | 2022 | 250 | 0.170 |
Why?
| | Scotland | 1 | 2019 | 12 | 0.170 |
Why?
| | Pre-Eclampsia | 1 | 2022 | 185 | 0.170 |
Why?
| | Problem Behavior | 1 | 2021 | 92 | 0.170 |
Why?
| | Precision Medicine | 1 | 2023 | 384 | 0.160 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 380 | 0.160 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 335 | 0.160 |
Why?
| | Acetylcarnitine | 1 | 2018 | 4 | 0.160 |
Why?
| | Aminoisobutyric Acids | 1 | 2018 | 7 | 0.150 |
Why?
| | Health Surveys | 1 | 2021 | 491 | 0.150 |
Why?
| | Fasting | 1 | 2020 | 264 | 0.150 |
Why?
| | Hydroxyproline | 1 | 2018 | 22 | 0.150 |
Why?
| | Ornithine | 1 | 2018 | 26 | 0.150 |
Why?
| | Asparagine | 1 | 2018 | 29 | 0.150 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 854 | 0.150 |
Why?
| | Models, Theoretical | 1 | 2022 | 541 | 0.150 |
Why?
| | Pilot Projects | 1 | 2023 | 1559 | 0.150 |
Why?
| | Sleep | 1 | 2024 | 675 | 0.150 |
Why?
| | Feces | 1 | 2021 | 435 | 0.150 |
Why?
| | Milk, Human | 1 | 2020 | 149 | 0.150 |
Why?
| | Carnitine | 1 | 2018 | 76 | 0.150 |
Why?
| | Phospholipids | 1 | 2019 | 207 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 229 | 0.150 |
Why?
| | Comorbidity | 1 | 2023 | 1537 | 0.150 |
Why?
| | Immunoglobulin G | 1 | 2022 | 842 | 0.140 |
Why?
| | Infant, Small for Gestational Age | 1 | 2018 | 84 | 0.140 |
Why?
| | History, 21st Century | 1 | 2018 | 177 | 0.140 |
Why?
| | Economic Development | 1 | 2017 | 3 | 0.140 |
Why?
| | Smoking | 1 | 2025 | 1459 | 0.140 |
Why?
| | Pediatrics | 3 | 2024 | 1044 | 0.140 |
Why?
| | Mass Spectrometry | 2 | 2018 | 662 | 0.140 |
Why?
| | Energy Metabolism | 2 | 2021 | 831 | 0.140 |
Why?
| | Risk Assessment | 2 | 2024 | 3223 | 0.140 |
Why?
| | Health Promotion | 1 | 2023 | 716 | 0.140 |
Why?
| | Snacks | 2 | 2015 | 19 | 0.140 |
Why?
| | Glucocorticoids | 1 | 2021 | 572 | 0.130 |
Why?
| | Dietary Fats | 2 | 2018 | 301 | 0.130 |
Why?
| | Mexican Americans | 1 | 2017 | 113 | 0.130 |
Why?
| | Glucose Tolerance Test | 1 | 2017 | 356 | 0.130 |
Why?
| | Glucose | 1 | 2021 | 983 | 0.120 |
Why?
| | Prehypertension | 1 | 2015 | 27 | 0.120 |
Why?
| | Trans Fatty Acids | 1 | 2015 | 6 | 0.120 |
Why?
| | Cognition | 1 | 2023 | 1104 | 0.120 |
Why?
| | Anxiety | 1 | 2022 | 951 | 0.120 |
Why?
| | Developing Countries | 1 | 2017 | 285 | 0.120 |
Why?
| | Risk | 1 | 2018 | 850 | 0.120 |
Why?
| | Prognosis | 3 | 2021 | 3766 | 0.120 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 248 | 0.120 |
Why?
| | Pregnancy Trimesters | 1 | 2014 | 16 | 0.120 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2015 | 104 | 0.120 |
Why?
| | Aging | 2 | 2023 | 1745 | 0.120 |
Why?
| | Body Weights and Measures | 1 | 2014 | 34 | 0.120 |
Why?
| | Urban Population | 1 | 2017 | 440 | 0.110 |
Why?
| | Infant, Premature | 1 | 2018 | 536 | 0.110 |
Why?
| | Mitochondria | 1 | 2020 | 847 | 0.110 |
Why?
| | Adaptation, Physiological | 1 | 2018 | 513 | 0.110 |
Why?
| | Los Angeles | 1 | 2013 | 63 | 0.110 |
Why?
| | New York City | 1 | 2013 | 80 | 0.110 |
Why?
| | Epigenomics | 2 | 2024 | 110 | 0.110 |
Why?
| | Carbonated Beverages | 1 | 2013 | 16 | 0.110 |
Why?
| | Iron Overload | 1 | 2013 | 12 | 0.100 |
Why?
| | Food, Fortified | 1 | 2013 | 37 | 0.100 |
Why?
| | Dietary Sucrose | 1 | 2013 | 48 | 0.100 |
Why?
| | Nutrition Policy | 1 | 2013 | 56 | 0.100 |
Why?
| | Animals | 6 | 2021 | 34487 | 0.100 |
Why?
| | Vitamin A | 1 | 2012 | 55 | 0.100 |
Why?
| | Ferritins | 1 | 2012 | 58 | 0.100 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 57 | 0.100 |
Why?
| | Sweden | 1 | 2012 | 92 | 0.100 |
Why?
| | Maternal Age | 1 | 2012 | 123 | 0.100 |
Why?
| | CpG Islands | 2 | 2024 | 151 | 0.090 |
Why?
| | Vitamin B 12 | 1 | 2012 | 122 | 0.090 |
Why?
| | Folic Acid | 1 | 2012 | 184 | 0.090 |
Why?
| | Signal Transduction | 2 | 2022 | 4812 | 0.090 |
Why?
| | Energy Intake | 2 | 2024 | 454 | 0.090 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2013 | 232 | 0.090 |
Why?
| | Iron | 1 | 2012 | 282 | 0.090 |
Why?
| | Immunization Programs | 1 | 2012 | 212 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2013 | 239 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1185 | 0.080 |
Why?
| | Diet Surveys | 2 | 2021 | 92 | 0.080 |
Why?
| | Zinc | 1 | 2012 | 292 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2023 | 3324 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2598 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2703 | 0.070 |
Why?
| | SRS-A | 1 | 1987 | 30 | 0.070 |
Why?
| | Medicaid | 1 | 2012 | 433 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5353 | 0.070 |
Why?
| | Bronchial Provocation Tests | 1 | 1987 | 50 | 0.070 |
Why?
| | Prednisolone | 1 | 1987 | 82 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2022 | 14404 | 0.070 |
Why?
| | Muscles | 2 | 2022 | 322 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2013 | 756 | 0.070 |
Why?
| | Mass Screening | 1 | 2013 | 1145 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2024 | 3009 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 1272 | 0.060 |
Why?
| | Hot Flashes | 1 | 2025 | 81 | 0.060 |
Why?
| | Esters | 1 | 2024 | 74 | 0.060 |
Why?
| | Organophosphates | 1 | 2024 | 120 | 0.050 |
Why?
| | Academic Success | 1 | 2023 | 26 | 0.050 |
Why?
| | Child Care | 1 | 2023 | 26 | 0.050 |
Why?
| | Parity | 1 | 2023 | 120 | 0.050 |
Why?
| | Accelerometry | 1 | 2023 | 91 | 0.050 |
Why?
| | Oxylipins | 1 | 2023 | 31 | 0.050 |
Why?
| | Sugars | 1 | 2023 | 37 | 0.050 |
Why?
| | Adipokines | 1 | 2023 | 47 | 0.050 |
Why?
| | Life Style | 2 | 2016 | 459 | 0.050 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2022 | 13 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7029 | 0.050 |
Why?
| | Starch | 1 | 2022 | 22 | 0.050 |
Why?
| | Longevity | 1 | 2023 | 149 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2024 | 1194 | 0.050 |
Why?
| | Cardiology | 1 | 2024 | 260 | 0.050 |
Why?
| | Allergens | 1 | 2024 | 381 | 0.050 |
Why?
| | Food | 1 | 2022 | 154 | 0.050 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2022 | 159 | 0.050 |
Why?
| | Menstrual Cycle | 1 | 2022 | 121 | 0.040 |
Why?
| | Lipase | 1 | 2021 | 64 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 303 | 0.040 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 207 | 0.040 |
Why?
| | Dietary Exposure | 1 | 2020 | 5 | 0.040 |
Why?
| | Louisiana | 1 | 2020 | 27 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 607 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 151 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 98 | 0.040 |
Why?
| | Genetic Markers | 1 | 2021 | 338 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 369 | 0.040 |
Why?
| | Telomere | 1 | 2022 | 226 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2020 | 85 | 0.040 |
Why?
| | Gene-Environment Interaction | 1 | 2021 | 185 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 709 | 0.040 |
Why?
| | Eating | 1 | 2022 | 368 | 0.040 |
Why?
| | Quality of Life | 2 | 2025 | 2672 | 0.040 |
Why?
| | Public Health | 1 | 2023 | 478 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3371 | 0.040 |
Why?
| | Edible Grain | 1 | 2018 | 48 | 0.040 |
Why?
| | Genitalia | 1 | 2018 | 30 | 0.040 |
Why?
| | Particulate Matter | 1 | 2020 | 245 | 0.040 |
Why?
| | Cities | 1 | 2018 | 105 | 0.040 |
Why?
| | Menarche | 1 | 2018 | 58 | 0.040 |
Why?
| | Behavior, Animal | 1 | 2021 | 485 | 0.040 |
Why?
| | Testis | 1 | 2018 | 144 | 0.040 |
Why?
| | Social Class | 1 | 2019 | 258 | 0.030 |
Why?
| | Dietary Carbohydrates | 1 | 2018 | 150 | 0.030 |
Why?
| | Breast | 1 | 2018 | 152 | 0.030 |
Why?
| | Meat | 1 | 2018 | 93 | 0.030 |
Why?
| | Autoimmunity | 1 | 2023 | 860 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2018 | 128 | 0.030 |
Why?
| | Lactation | 1 | 2018 | 170 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 377 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1628 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2016 | 77 | 0.030 |
Why?
| | Linoleic Acid | 1 | 2015 | 41 | 0.030 |
Why?
| | Oleic Acid | 1 | 2015 | 39 | 0.030 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2015 | 51 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 725 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2021 | 1105 | 0.030 |
Why?
| | Aged | 1 | 2013 | 21892 | 0.030 |
Why?
| | Research Design | 1 | 2020 | 1034 | 0.030 |
Why?
| | Vitamin D | 1 | 2018 | 380 | 0.030 |
Why?
| | Notophthalmus viridescens | 1 | 1993 | 1 | 0.030 |
Why?
| | Radio | 1 | 2013 | 2 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2018 | 531 | 0.030 |
Why?
| | Salamandridae | 1 | 1993 | 26 | 0.030 |
Why?
| | Tanzania | 1 | 2013 | 44 | 0.030 |
Why?
| | Depression | 1 | 2022 | 1290 | 0.030 |
Why?
| | Consumer Health Information | 1 | 2013 | 48 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2261 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2059 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1993 | 541 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1356 | 0.020 |
Why?
| | Information Systems | 1 | 2012 | 60 | 0.020 |
Why?
| | Acclimatization | 1 | 1993 | 160 | 0.020 |
Why?
| | Models, Statistical | 1 | 2014 | 621 | 0.020 |
Why?
| | Models, Biological | 1 | 2018 | 1689 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 174 | 0.020 |
Why?
| | Rural Population | 1 | 2013 | 511 | 0.020 |
Why?
| | Data Collection | 1 | 2012 | 645 | 0.020 |
Why?
| | Airway Resistance | 1 | 1987 | 38 | 0.020 |
Why?
| | Vaccines | 1 | 2012 | 394 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10110 | 0.010 |
Why?
| | Parents | 1 | 2012 | 1303 | 0.010 |
Why?
| | Phosphocreatine | 1 | 1993 | 40 | 0.010 |
Why?
| | Phosphates | 1 | 1993 | 169 | 0.010 |
Why?
| | Species Specificity | 1 | 1993 | 568 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1993 | 510 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1993 | 469 | 0.010 |
Why?
| | Temperature | 1 | 1993 | 628 | 0.010 |
Why?
|
|
Perng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|